Published in Am J Obstet Gynecol on September 01, 1991
Potential prenatal predictions of Down syndrome: a statistical analysis. Am J Obstet Gynecol (1990) 1.62
Handwashing compliance by health care workers: The impact of introducing an accessible, alcohol-based hand antiseptic. Arch Intern Med (2000) 2.10
The role of CA125 in clinical practice. J Clin Pathol (2005) 1.81
Chemistry of nonenzymic browning. II. Adv Food Res (1965) 1.77
Serum screening for Down's syndrome. Br J Obstet Gynaecol (1993) 1.66
The mathematical basis of multivariate risk screening: with special reference to screening for Down's syndrome associated pregnancy. Ann Clin Biochem (1990) 1.56
The effects of gestation dating on the calculation of patient specific risks in Down's syndrome screening. Ann Clin Biochem (1995) 1.46
Best practice in primary care pathology: review 3. J Clin Pathol (2006) 1.45
Software for screening to assess risk of Down's syndrome. BMJ (1991) 1.44
Measurement of intestinal calcium absorption by using stable strontium. Clin Sci (Lond) (1995) 1.39
Assessment of atypicality: an adjunct to prenatal screening for Down's syndrome that facilitates detection of other abnormalities. Ann Clin Biochem (1993) 1.39
Down's syndrome screening in twin pregnancies. Prenat Diagn (1995) 1.37
A comparison of algorithms for initiation of lipid lowering therapy in primary prevention of coronary heart disease. J Cardiovasc Risk (2000) 1.18
The prevalence of iron deficiency among patients presenting with colorectal cancer. Colorectal Dis (2005) 1.11
Correlation of specific gravity and osmolality of urine in neonates and adults. Arch Dis Child (1987) 1.07
Health promotion in general practice. Any beneficial effect was lost in background statistical noise. BMJ (1995) 1.07
Effects of statins. Lancet (2000) 1.06
Use of statins. Standing Medical Advisory Committee should reconsider advice to use Sheffield risk table. BMJ (1997) 1.06
Chemical pathology and the new contract for GPs. J Clin Pathol (2004) 1.03
Best practice in primary care pathology: review 4. J Clin Pathol (2006) 1.00
Antenatal screening for Down's syndrome. Lancet (1998) 0.98
Microalbuminuria is an early response following acute myocardial infarction. Eur Heart J (1991) 0.98
Total research productivity in a pathology discipline. J Clin Pathol (2002) 0.97
Corpus cavernosum penis pressure and penile muscle activity in the bull during coitus. Am J Vet Res (1974) 0.97
Best practice in primary care pathology: review 6. J Clin Pathol (2006) 0.93
Is clinical pathology accreditation worth it? A survey of CPA-accredited laboratories. Clin Perform Qual Health Care (2000) 0.93
Drug treatment of hypercholesterolaemia. Establish diagnosis before treatment. BMJ (1994) 0.90
All MoMs are not equal: some statistical properties associated with reporting results in the form of multiples of the median. Am J Hum Genet (1993) 0.90
Comparison between transcutaneous bilirubinometry and total serum bilirubin measurements in preterm infants <35 weeks gestation. Ann Clin Biochem (2009) 0.89
Angiography of the crus penis in the ram and buck during erection. Am J Vet Res (1978) 0.88
Hemoglobin Old Dominion/Burton-upon-Trent, beta 143 (H21) His-->Tyr, codon 143 CAC-->TAC--a variant with altered oxygen affinity that compromises measurement of glycated hemoglobin in diabetes mellitus: structure, function, and DNA sequence. Mayo Clin Proc (1998) 0.87
Unilateral pulmonary oedema and Pseudomonas pneumonia. Postgrad Med J (1980) 0.87
Randomized comparison trial of the RIK and the Nimbus 3 mattresses. Br J Nurs (2003) 0.87
Popular medical information on Internet. Lancet (1995) 0.87
Resetting of osmoreceptor response as cause of hyponatraemia in acute idiopathic polyneuritis. Br Med J (1979) 0.87
Urinary prostaglandin E and antidiuretic hormone during water immersion in man. Clin Sci (Lond) (1985) 0.86
Severe recurrent renal salt wasting in a boy with a mitochondrial oxidative phosphorylation defect. Ann Clin Biochem (2000) 0.84
Adjusting copper concentrations for caeruloplasmin levels in routine clinical practice. J Clin Pathol (2006) 0.84
Sheffield risk and treatment table for cholesterol lowering in prevention of coronary heart disease. Lancet (1996) 0.84
The effect of weight correction on risk calculations for Down's syndrome screening. Ann Clin Biochem (1991) 0.83
Arginine infusion blocks the action of parathyroid hormone but not arginine vasopressin on the renal tubule in man. J Endocrinol (1986) 0.83
Corpus cavernosum penis pressure and external penile muscle activity during erection in the goat. Biol Reprod (1972) 0.83
The MDRD formula and validation. QJM (2006) 0.83
Ultrasonographic dating of pregnancy causes significant errors in Down syndrome risk assessment that may be minimized by use of biparietal diameter-based means. Am J Obstet Gynecol (1992) 0.83
The use and understanding of CA125 as a tumor marker for ovarian cancer: a questionnaire-based survey. Int J Gynecol Cancer (2007) 0.82
Tumour induced hypophosphataemia associated with small cell carcinoma of the bronchus. Thorax (1987) 0.82
Molecular epidemiology of vancomycin-resistant Enterococcus faecium in a large urban hospital over a 5-year period. J Clin Microbiol (1999) 0.81
Familial defective apolipoprotein B-100: a study of patients from lipid clinics in Scotland and Wales. Ann Clin Biochem (1996) 0.81
Excessive calcium ingestion leading to milk-alkali syndrome. Ann Clin Biochem (2008) 0.80
Thirst, resetting of the osmostat, and water intoxication following encephalitis. Ann Neurol (1983) 0.80
The copper/caeruloplasmin ratio in routine clinical practice in different laboratories. J Clin Pathol (2009) 0.80
Vascular risk screening: possible or too much, too soon? Int J Clin Pract (2009) 0.79
Evaluation of four animal models of intrarenal calcium deposition and assessment of the influence of dietary supplementation with essential fatty acids on calcification. Urol Res (1995) 0.79
Pulsatile release of arginine vasopressin (AVP) and it's effect on response to desmopressin in enuresis. Scand J Urol Nephrol Suppl (1994) 0.79
Lipid lowering therapy in patients with HIV infection. Lancet (1998) 0.78
How accurate are pressure ulcer grades? An image-based survey of nurse performance. J Tissue Viability (2001) 0.78
The relationship between plasma lithium and the renal responsiveness to arginine vasopressin in man. Clin Sci (Lond) (1981) 0.78
Chronic reset osmoreceptor response, agenesis of the corpus callosum, and hypothalamic cyst. J Pediatr (1984) 0.78
Response to: Wald, N.J., Hackshaw, A.K. (1997). Combining ultrasound and biochemistry in first-trimester screening for Down's syndrome, Prenat. Diagn., 17, 821-829. Prenat Diagn (1998) 0.77
Prescribing high-dose lipid-lowering therapy early to avoid subsequent cardiovascular events: is this a cost-effective strategy? Eur J Prev Cardiol (2011) 0.77
Increased maternal serum free beta human chorionic gonadotrophin concentrations in Down's pregnancies: an artefactual finding? Br J Obstet Gynaecol (1994) 0.77
An open, in-patient incremental safety and efficacy study of desmopressin in women with multiple sclerosis and nocturia. Br J Urol (1995) 0.77
Analysis of the components of the hypercalcaemia in a 14-year-old boy following prolonged immobilisation. Acta Paediatr Scand (1983) 0.77
Reduced renal hemodynamic response to atrial natriuretic peptide in elderly volunteers. Am J Kidney Dis (1993) 0.76
Familial ligand-defective apolipoprotein B-100: detection, biochemical features and haplotype analysis of the R3531C mutation in the UK. Atherosclerosis (1997) 0.76
Early diagnosis of ectopic arginine vasopressin secretion. Clin Chem (1993) 0.76
The frusemide test: simple screening test for renal acidification defect in urolithiasis. Br J Urol (1993) 0.76
Relationship between serum alkaline phosphatase and pyridoxal-5'-phosphate levels in hypophosphatasia. Clin Sci (Lond) (1998) 0.75
Measurement of atherosclerosis progression. Lancet (2001) 0.75
Prenatal screening for trisomy 18. Prenat Diagn (1996) 0.75
Survival and reduction in mortality from breast cancer. Improvements in survival may be an illusion. BMJ (2000) 0.75
Are drugs interchangeable? Lancet (2000) 0.75
Statin precipitated lactic acidosis? J Clin Pathol (2004) 0.75
Down's syndrome screening in the UK. Lancet (1996) 0.75
Vitamin K and metabolic bone disease. J Clin Pathol (1998) 0.75
Mortality and alcohol consumption. The conclusions we draw. BMJ (1995) 0.75
Classification of acute MI. Eur Heart J (2000) 0.75
Screening for secondary causes of hyperlipidaemia in general practice. Correct diagnosis needs to be established. BMJ (1994) 0.75
Cost effectiveness of statins. Heart (2000) 0.75
Heel ulcer prevention. J Wound Care (2001) 0.75
Cardiac troponin T in unstable angina. Troponin T could be used to identify patients needing early treatment. BMJ (1996) 0.75
Cholesterol: how low is low enough? Doctors have been slow in getting evidence on lowering cholesterol into practice. BMJ (1999) 0.75
Statins and fractures. Lancet (2001) 0.75
First trimester biochemical screening for trisomy 21. Ann Clin Biochem (1995) 0.75
Decision analysis and screening for Down's syndrome. Costs were overestimated. BMJ (1995) 0.75
Is a mechanical or a metabolic approach superior in the treatment of coronary disease? Results of the atorvastatin versus revascularization (AVERT) trial. Eur Heart J (2001) 0.75
Strategies for reducing coronary risk factors in primary care. BMJ (1995) 0.75
Familial hyperchylomicronaemia. Lancet (1996) 0.75
Swabaholics? Lancet (1995) 0.75
Time for SI units. Lancet (1998) 0.75
MOMs (multiples of the median) may know best: there are insufficient data to suggest that DADs (discriminant aneuploidy detection) are superior. Am J Obstet Gynecol (1995) 0.75
Use of statins. Guidelines need to concentrate on reducing overall cardiovascular risk. BMJ (1997) 0.75
People at risk of coronary heart disease should not be denied treatment with effective drugs for purely financial reasons. BMJ (1998) 0.75
Vitamin B6 deficiency may also be important. Clin Chem (1998) 0.75
National service framework's financial implications are huge. BMJ (2000) 0.75
Glycated haemoglobin values. Methodological discrepancies are not important. BMJ (1994) 0.75
Cost effectiveness of lowering cholesterol. Full treatment of the costs and benefits is needed. BMJ (1996) 0.75
Sheffield risk and treatment table for primary prevention of coronary heart disease. Lancet (1996) 0.75
Limitations of non-ceruloplasmin-bound copper in routine clinical practice. Gut (2007) 0.75
The casino of life. J Clin Pathol (2004) 0.75